PHAR NASDAQ
Pharming Group N.V.
1W: -6.8%
1M: -12.9%
3M: -31.9%
YTD: -43.1%
1Y: -36.6%
3Y: -30.0%
5Y: +0.5%
$9.75
-0.20 (-2.01%)
Weekly Expected Move ±6.1%
$9
$9
$10
$10
$11
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$43M
+2474.6% ▲
5Y CAGR: -12.6%
Capital Expenditures
$639K
+19.7% ▲
5Y CAGR: -47.0%
Free Cash Flow
$42M
+1720.4% ▲
5Y CAGR: -9.3%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$78M
+1241.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $23M | $15M | -$12M | -$8M | $2M |
| Depreciation & Amort. | $20M | $13M | $16M | $16M | $0 |
| Stock-Based Comp. | $9M | $6M | $9M | $11M | $0 |
| Change in Working Capital | -$5M | -$387K | -$17M | -$10M | $12M |
| Other Non-Cash Items | -$9M | -$12M | -$14M | -$11M | $28M |
| Operating Cash Flow | $38M | $22M | -$17M | -$2M | $43M |
| — Investing Activities — | |||||
| Capital Expenditures | -$17M | -$2M | -$1M | -$796K | -$645K |
| Acquisitions (Net) | $0 | $7M | $0 | $0 | -$56M |
| Investment Purchases | -$5M | $0 | -$382M | -$284M | $0 |
| Investment Sales | $0 | $0 | $233M | $317M | $0 |
| Other Investing | $0 | $0 | $21M | $0 | $72M |
| Investing Cash Flow | -$21M | $5M | -$129M | $32M | $16M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$3M | -$3M | -$4M | -$34M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$29M | -$4M | $3M | -$19K | -$5M |
| Financing Cash Flow | -$28M | -$5M | -$1M | -$34M | $12M |
| Net Change in Cash | -$13M | $15M | -$146M | -$7M | $78M |
| Cash End of Period | $192M | $207M | $62M | $55M | $124M |
| Free Cash Flow | $21M | $20M | -$19M | -$3M | $42M |